Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy

Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy

Nivolumab improves overall survival (OS) in patients with advanced gastric cancer (AGC) refractory to at least two previous chemotherapy regimens. We investigated whether changes in body weight and nutrition from first-line chemotherapy to nivolumab affected its efficacy. The correlation between wei...

Full description

Bibliographic Details
Main Authors: Tatsuki Ikoma, Toshihiko Matsumoto, Yusuke Kurioka, Masahiro Takatani, Hiroki Nagai, Yusuke Matsumoto, Hironaga Satake, Hisateru Yasui
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
nivolumab
gastric cancer
nutritional status
body weight loss
chemotherapy
Online Access:https://www.mdpi.com/2077-0383/11/20/6100

Internet

https://www.mdpi.com/2077-0383/11/20/6100

Similar Items